Kezar Life Sciences (KZR) Research & Development (2021 - 2025)
Kezar Life Sciences (KZR) has disclosed Research & Development for 5 consecutive years, with $5.1 million as the latest value for Q4 2025.
- Quarterly Research & Development fell 68.32% to $5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.8 million through Dec 2025, down 48.65% year-over-year, with the annual reading at $33.8 million for FY2025, 48.65% down from the prior year.
- Research & Development hit $5.1 million in Q4 2025 for Kezar Life Sciences, down from $6.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $23.7 million in Q3 2023 to a low of $5.1 million in Q4 2025.
- Historically, Research & Development has averaged $13.8 million across 5 years, with a median of $13.0 million in 2022.
- Biggest five-year swings in Research & Development: surged 85.08% in 2023 and later plummeted 68.32% in 2025.
- Year by year, Research & Development stood at $9.8 million in 2021, then skyrocketed by 51.92% to $14.9 million in 2022, then skyrocketed by 52.38% to $22.6 million in 2023, then dropped by 29.2% to $16.0 million in 2024, then tumbled by 68.32% to $5.1 million in 2025.
- Business Quant data shows Research & Development for KZR at $5.1 million in Q4 2025, $6.9 million in Q3 2025, and $9.6 million in Q2 2025.